×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
How it Works
🎨
Pitch
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
How it Works
Pitch
Showcase
Demo
←
Home
/
Wiki
/
Index: Events
index
744 words
2026-03-29
kind:index
section:events
Contents
Events
Related Hypotheses (30)
Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.51
Multi-Target Hypothesis: Aβ-Induced Cholinergic Damage is Pa
Score: 0.70
Closed-loop focused ultrasound targeting EC-II SST interneur
Score: 0.70
Gamma entrainment therapy to restore hippocampal-cortical sy
Score: 0.68
Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna
Score: 0.68
Transcriptional Autophagy-Lysosome Coupling
Score: 0.66
Closed-loop optogenetic targeting PV interneurons to restore
Score: 0.63
CYP46A1 Overexpression Gene Therapy
Score: 0.63
Closed-loop tACS targeting entorhinal cortex layer II SST in
Score: 0.62
p38α Inhibitor and PRMT1 Activator Combination to Restore Ph
Score: 0.61
Closed-loop transcranial focused ultrasound targeting EC-II
Score: 0.61
Gut Microbiome Remodeling to Prevent Systemic NLRP3 Priming
Score: 0.61
Multi-Modal Stress Response Harmonization
Score: 0.60
PARP1 Inhibition Therapy
Score: 0.58
Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu
Score: 0.57
Synthetic Biology BBB Endothelial Cell Reprogramming
Score: 0.57
SASP-Mediated Cholinergic Synapse Disruption
Score: 0.56
Smartphone-Detected Motor Variability Correction
Score: 0.56
Adenosine-Astrocyte Metabolic Reset
Score: 0.56
Senescent Microglia Resolution via Maresins-Senolytics Combi
Score: 0.55
Ferroptosis Inhibition for α-Synuclein Neuroprotection
Score: 0.55
Neutral Sphingomyelinase-2 Inhibition for Synaptic Protectio
Score: 0.55
Microglial-Mediated Tau Clearance Dysfunction via TREM2 Sign
Score: 0.53
Senescence-Induced Lipid Peroxidation Spreading
Score: 0.53
Multiplexed Base Editing for Simultaneous Neuroprotective Ge
Score: 0.53
Astrocyte-Selective APOE4 Silencing via Lipid Nanoparticles
Score: 0.53
Microglial TREM2-Complement Axis Modulation
Score: 0.53
Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.53
Vagal Afferent Microbial Signal Modulation
Score: 0.52
Phase-Separated Organelle Targeting
Score: 0.52
Show 25 more
Related Analyses (30)
Do perinatal immune challenges create persistent epigenetic
developmental neurobiology · failed
Does SPP1-mediated synaptic engulfment represent beneficial
synaptic biology · failed
What are the neuron-specific effects of ALS-causing mutation
neurodegeneration · failed
What are the minimal structural requirements for HSP70/HSP90
drug discovery · completed
Do tau strains or regional cellular environments primarily d
neurodegeneration · failed
What is the optimal ketone dosing threshold to avoid metabol
neurometabolism · failed
What is the high-resolution structure of the APOE4 hinge reg
structural biology · failed
What is the therapeutic window between insufficient and toxi
neurodegeneration · completed
What determines blood-brain barrier penetration kinetics for
neuropharmacology · failed
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived
Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived
Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived
Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived
Mitochondrial transfer between neurons and glia
neurodegeneration · archived
Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed
Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived
Synaptic pruning by microglia in early AD
neurodegeneration · archived
Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived
Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived
Perivascular spaces and glymphatic clearance failure in AD
neurodegeneration · archived
Circuit-level neural dynamics in neurodegeneration
neuroscience · archived
Epigenetic reprogramming in aging neurons
neurodegeneration · archived
Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived
SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas
neurodegeneration · completed
Show 25 more
Related Experiments (30)
Intensive Medical Treatment vs Usual Care in Women with ANOC
clinical · proposed · Score: 0.95
Brain Connectivity-Targeted tACS Trial in Early AD
clinical · proposed · Score: 0.95
Literature Review of TRT-Induced Erythrocytosis Risk
clinical · proposed · Score: 0.90
Spp1 knockout prevents synaptic loss in AD mouse models
validation · proposed · Score: 0.90
VSMC cholesterol efflux and P2RY12 signaling
exploratory · proposed · Score: 0.90
TDP-43 mitochondrial invasion and mtDNA release in iPSC moto
exploratory · proposed · Score: 0.90
IRF1 transcriptional regulation of Nlrc5 and Ciita promoters
exploratory · proposed · Score: 0.90
CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs
clinical · proposed · Score: 0.90
PGC-1α knockout analysis of PV+ interneuron maturation
validation · proposed · Score: 0.85
Confocal imaging of MSC-chondrocyte interactions during mito
exploratory · proposed · Score: 0.85
In vitro DDR reconstitution on nucleosomes
exploratory · proposed · Score: 0.80
Analysis of TP53-TP63/ΔNP63-EFNB1-EPHB4 axis in cancer progr
exploratory · proposed · Score: 0.75
s:** - Temporal analysis showing mitochondrial defects prece
falsification · proposed · Score: 0.40
Proposed experiment from debate on TDP-43 undergoes liquid-l
falsification · proposed · Score: 0.40
Proposed experiment from debate on Mitochondrial transfer be
falsification · proposed · Score: 0.40
Proposed experiment from debate on Mitochondrial transfer be
falsification · proposed · Score: 0.40
Biomechanical Impact Profiles and Chronic Traumatic Encephal
clinical · proposed · Score: 0.40
4R-Tau Targeting Therapies for PSP and CBS
clinical · proposed · Score: 0.40
AAV-LRRK2 IND-Enabling Study Design
clinical · proposed · Score: 0.40
AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi
clinical · proposed · Score: 0.40
AD Combination Therapy Trial: Anti-Aβ + Anti-Tau
clinical · proposed · Score: 0.40
Alpha-Synuclein SAA Kinetics Study — Biological Staging Back
clinical · proposed · Score: 0.40
Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio
clinical · proposed · Score: 0.40
Basic Mechanism: Membrane-Driven Alpha-Synuclein Nucleation
validation · proposed · Score: 0.40
Alpha-Synuclein Seed Amplification Assay Validation
clinical · proposed · Score: 0.40
Alpha-Synuclein Spreading Mechanism — Prion-Like Propagation
exploratory · proposed · Score: 0.40
Metabolic Pathway-Targeted Therapy in ALS
clinical · proposed · Score: 0.40
ALS Progression Rate Heterogeneity — mechanism and biomarker
clinical · proposed · Score: 0.40
ALS Regional Onset and Spread: Network-Level Staging Model
clinical · proposed · Score: 0.40
Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk
clinical · proposed · Score: 0.40
Show 25 more
Knowledge Graph (8 edges)
Metabolites
biomarker_for
Cardiovascular events
Redox-Regulated Events
involved_in
Alzheimer Disease Pathogenesis
Redox-Regulated Events
involved_in
Alzheimer Disease Progression
Low-Density Lipoprotein Cholesterol
risk_factor_for
Recurrent Cardiovascular Events
Modified Antibody
associated_with
Adverse Events
Weight Reduction
protects_against
Cardiovascular Events
High-Sensitivity C-Reactive Protein
biomarker_for
Cardiovascular Events
LDL Cholesterol
biomarker_for
Cardiovascular Events